The study demonstrated the crucial role of Sirt1 gene in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) related to the influence of Sirt1 on oxidative stress and glycolipid metabolism. The 16-week-old genetically diabetic db/db mice were characterized with downregulated expression of Sirt1 in the liver accompanied by hepatomegaly and a larger size of fat vacuoles in hepatocytes. In db/m mice, silencing Sirt1 gene induced hepatic steatosis and significantly increased serum AST. Additionally, the levels of triglycerides in blood and liver of these mice were elevated. However, all pathological changes in the liver of Sirt1-knockdown db/m mice were less pronounced than in 16-week-old db/db mice. Further experiments showed that oxidative stress and PGC-1α-mediated mitochondrial dysfunction are implicated in pathological changes of lipid metabolism in T2DM-induced NAFLD provoked by Sirt1 silencing. This study showed that down-regulation of Sirt1 expression plays the key role in pathological processes developed during T2DM-induced abnormalities of lipid metabolism in the liver. Thus, up-regulation of Sirt1 expression seems to be a promising strategy in early prevention of T2DM-induced NAFLD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ding RB, Bao J, Deng CX. Emerging roles of SIRT1 in fatty liver diseases. Int. J. Biol. Sci. 2017;13(7):852-867. doi: https://doi.org/10.7150/ijbs.19370
Grattagliano I, Montezinho LP, Oliveira PJ, Frühbeck G, Gómez- Ambrosi J, Montecucco F, Carbone F, Wieckowski MR, Wang DQ, Portincasa P. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochem. Pharmacol. 2019;160:34-45. doi: https://doi.org/10.1016/j.bcp.2018.11.020
Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell. Mol. Life Sci. 2018;75(18):3313-3327. doi: https://doi.org/10.1007/s00018-018-2860-6
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109-1122. doi: https://doi.org/10.1016/j.cell.2006.11.013
Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, Tikhaze AK, Ageev FT, Kukharchuk VV, Belenkov YN. Oxidative stress in atherosclerosis and diabetes. Bull. Exp. Biol. Med. 2005;140(1):41-43. doi: https://doi.org/10.1007/s10517-005-0406-z
Lee G, Uddin MJ, Kim Y, Ko M, Yu I, Ha H. PGC-1α, a potential therapeutic target against kidney aging. Aging Cell. 2019;18(5):e12994. doi: https://doi.org/10.1111/acel.12994
Li L, Liu M, Cao M, He T, Bai X. Research progress on SIRT1 and sepsis. Histol. Histopathol. 2019;34(11):1205-1215. doi: https://doi.org/10.14670/HH-18-146
McCommis KS, Finck BN. Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism. Cell. Mol. Gastroenterol. Hepatol. 2019;7(2):275-284. doi: https://doi.org/10.1016/j.jcmgh.2018.09.017
Noureddin M, Rinella ME. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin. Liver Dis. 2015;19(2):361-379. doi: https://doi.org/10.1016/j.cld.2015.01.012
Yang JD, Ahmed F, Mara KC, Addissie BD, Allen AM, Gores GJ, Roberts LR. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology. 2020;71(3):907-916. doi: https://doi.org/10.1002/hep.30858
Yang T, Yang H, Heng C, Wang H, Chen S, Hu Y, Jiang Z, Yu Q, Wang Z, Qian S, Wang J, Wang T, Du L, Lu Q, Yin X. Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice. Food Funct. 2020;11(12):10675-10689. doi: https://doi.org/10.1039/d0fo01954b
Yu A, Dang W. Regulation of stem cell aging by SIRT1 - Linking metabolic signaling to epigenetic modifications. Mol. Cell Endocrinol. 2017;(455):75-82. doi: https://doi.org/10.1016/j.mce.2017.03.031
Yu Q, Dong L, Li Y, Liu G. SIRT1 and HIF1alpha signaling in metabolism and immune responses. Cancer Lett. 2018;418:20-26. doi: https://doi.org/10.1016/j.canlet.2017.12.035
Yuan D, Xiao D, Gao Q, Zeng L. PGC-1alpha activation: a therapeutic target for type 2 diabetes? Eat Weight Disord. 2019;24(3):385-395. doi: https://doi.org/10.1007/s40519-018-0622-y
Zhu S, Dong Z, Ke X, Hou J, Zhao E, Zhang K, Wang F, Yang L, Xiang Z, Cui H. The roles of sirtuins family in cell metabolism during tumor development. Semin. Cancer Biol. 2019;57:59-71. doi: https://doi.org/10.1016/j.semcancer.2018.11.003
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 8, pp. 212-218, August, 2021
Rights and permissions
About this article
Cite this article
Yang, H., Liu, Y., Wang, Y. et al. Knockdown of Sirt1 Gene in Mice Results in Lipid Accumulation in the Liver Mediated via PGC-1α-Induced Mitochondrial Dysfunction and Oxidative Stress. Bull Exp Biol Med 172, 180–186 (2021). https://doi.org/10.1007/s10517-021-05359-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05359-1